The International Center for Blood and Marrow Transplant Research celebrates its 50th anniversary

SALT LAKE CITY–(BUSINESS WIRE)–2022 marks the 50and anniversary of the Center for International Blood and Marrow Transplant Research® (CIBMTR®). The CIBMTR® is a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW).

Cell therapy has come a long way from its roots in the 1950s Cold War, from experimental treatment for radiation sickness to standard therapy for leukemia, lymphoma and sickle cell disease. Now, cell therapy includes both blood and bone marrow transplantation and other adoptive cell therapies.

The story began in 1972, when a handful of doctors from the United States, France and the Netherlands created an international transplant registry to see which therapies helped people the most. Over time, this informal alliance grew to involve many other countries and a formal research collaboration between the Medical College of Wisconsin (MCW) and the National Marrow Donor Program® (NMDP) / Be The Match®.

Today, CIBMTR receives data from approximately 350 medical centers around the world and has analyzed the clinical outcomes of 600,000 people who have undergone blood and bone marrow transplants. Recently, the CIBMTR has expanded to include data for other cell therapies, such as chimeric antigen receptor T-cell (CAR-T) therapy.

“Studies using data from CIBMTR’s large research database are driving practice change,” said Bronwen Shaw, MD, PhD, Chief Scientific Officer, CIBMTR MCW. “For example, real-world evidence analyzed by CIBMTR’s team of highly trained and expert personnel has paved the way for Medicare coverage of certain therapies and Food and Drug Administration (FDA) approval for d ‘others.”

“We’re testing faster ways to automate data collection and sharing,” said Jeffery Auletta, MD, Chief Scientific Officer, CIBMTR NMDP/Be The Match. “Promoting equitable access to cell therapies is a top priority.”

CIBMTR is celebrating on Sunday, April 24, 2022, from 8:30 a.m. to 10 a.m. MDT, at the Tandem 2022 I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Tandem Meetings are the combined annual meetings of CIBMTR and the American Society for Transplantation and Cellular Therapy (ASTCT), a professional organization for physicians, researchers, and healthcare professionals. The Tandem Meetings Plenary Session will be chaired by Mary M. Horowitz, MD, MS, Scientific Director Emeritus, CIBMTR MCW, and Amy Ronneberg, CEO of NMDP/Be The Match. Topics will include:

  • The Evolution of Donor Selectionby Stephen Spellman, MBS
  • CIBMTR precision medicine: beyond the HLAby Wael Saber, MD, MPH
  • Real-world CAR-T cell databy Marcelo C. Pasquini, MD, MS
  • From real-world data to clinical trialsby Steven M. Devine, MD

About CIBMTR

The Center for International Blood and Marrow Transplant Research is a nonprofit research collaboration between the National Marrow Donor Program (NMDP)/Be The Match, Minneapolis, and the Medical College of Wisconsin, Milwaukee. CIBMTR collaborates with the global scientific community to increase survival and enrich the quality of life of patients. CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, an extensive network of centers and a unique database of long-term clinical data for more than 600,000 people who have received hematopoietic cell transplants and other cell therapies. Learn more at cibmtr.org or follow CIBMTR on Facebook, LinkedIn or Twitter @CIBMTR.

About the National Marrow Donor Program/Be The Match

National Marrow Donor Program® (NMDP)/Be the Match® is the world’s leading partner working to save lives through cell therapy. With over 30 years of experience managing the most diverse registry of potential unrelated blood stem cell and cord blood unit donors in the world, NMDP/Be The Match is a proven partner in providing treatments for patients with life-threatening blood and spinal cord cancers and diseases. Through their global network, they connect centers and patients to their best cell therapy option – from blood stem cell transplantation to next-generation therapy – and collaborate with cell and gene therapy companies to support the development and providing therapies through Be The Match BioTherapies®. NMDP/Be The Match is a tireless advocate for the cell therapy community, working with hematologists/oncologists to break down barriers to consultation and treatment, and supporting patients through free programs to break down non-medical barriers to cell therapy. In addition, they are a world leader in research through the CIBMTR® (International Blood and Marrow Transplant Research Center®)—a collaboration with the Medical College of Wisconsin, which invests in and manages research studies that improve patient outcomes and advance the future of care.

About Medical College of Wisconsin

The Medical College of Wisconsin is dedicated to excellence in education, research, patient care, and community engagement. Approximately 1,400 medical, graduate, and pharmacy students are enrolled at MCW campuses in Milwaukee, Green Bay, and Wausau. A major national research center, MCW is the largest research institution in the Milwaukee metropolitan area and the second largest in Wisconsin. Over the past 10 years, faculty have received more than $1.4 billion in research funding, including highly competitive National Institutes of Health (NIH) research and training grants. More than 1,650 physicians provide care in almost every specialty of medicine to more than 2.6 million patients each year. Learn more at mcw.edu.

Comments are closed.